bendroflumethiazide and tacrolimus

bendroflumethiazide has been researched along with tacrolimus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bachmann, S; Conley, J; Ellison, DH; Fürstenberg, A; Hoorn, EJ; Howie, AJ; McCormick, JA; Paliege, A; Roeschel, T; Unwin, RJ; Walsh, SB; Yang, CL1

Reviews

1 review(s) available for bendroflumethiazide and tacrolimus

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for bendroflumethiazide and tacrolimus

ArticleYear
The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension.
    Nature medicine, 2011, Oct-02, Volume: 17, Issue:10

    Topics: Analysis of Variance; Animals; Bendroflumethiazide; Calcineurin Inhibitors; Calcium; Cell Line; Chlorides; Creatinine; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Hydrochlorothiazide; Hypertension; Immunoblotting; Immunohistochemistry; Kidney; Mice; Mice, Knockout; Sodium Chloride Symporters; Tacrolimus

2011